Amanat Acquisition Corp

Amanat Acquisition Corp

NNASDAQ:AMAN
10.11
USD
-0.01
(-0.11%)
0.01EPS
98.11MMarket Cap
Amanat Acquisition Corp
NASDAQ:AMAN
(Nasdaq Stock Market)

Recent

price

10.11

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available
Business
Amanat Acquisition Corp, a blank-check company focused on completing a merger, share exchange, asset acquisition, or similar business combination with a healthcare or healthcare-related business; headquartered in the United States and organized as a SPAC, the company aims to secure a controlled investment vehicle for a strategic healthcare target and to execute a transaction within a 24-month period. Main products and services - Primary business activity: formation and operation as a special purpose acquisition company (SPAC) intended to consummate a merger or other business combination with a target primarily in healthcare or healthcare-related industries; the SPAC structure itself is the core offering, enabling a subject company to access public markets through a pre-identified acquisition path. - Core investment and transaction services: capital deployment for a targeted healthcare business combination; facilitation of due diligence, regulatory filings, and merger integration planning; coordination with underwriters, legal counsel, auditors, and financial advisers for the de-SPAC process. - Public offering and listing services: structuring and marketing of the initial public offering (IPO) of Class A ordinary shares; managing trust account and proceeds for future acquisition purposes; arranging sponsor alignment and shareholder communication around the anticipated business combination. - Compliance, governance, and post-transaction support: maintaining fiduciary standards, investor disclosures, and governance structures; providing post-merger integration support and transition services for the combined entity, where applicable. Latest major company changes - Public listing plans and capital raise: files for a $75 million IPO for 7.5 million Class A ordinary shares, with proceeds intended to fund a future healthcare-focused business combination and maintain a trust balance for anticipated transactions; underwriters include Leerink Partners; preparation of SEC filings indicates active listing preparation on a U.S. exchange. - Regulatory and strategic positioning updates: communications indicate an intent to list on a major U.S. exchange under the ticker AMAN, with ongoing regulatory filings and readiness for a NASDAQ listing process; this reflects a significant strategic shift toward establishing a publicly traded vehicle for a healthcare-focused target. - Market and deal activity status: as of mid-2026, the company remains in the pre-IPO phase or early listing process, with a focus on finalizing transaction metrics, board and sponsor alignment, and securing regulatory approvals to advance a healthcare-focused business combination. Additional context - Industry and segments: healthcare and healthcare-related industries, including potential sub-sectors such as medical devices, healthcare services, biotechnology, digital health, or healthcare IT; the SPAC targets are typically established through strategic partnerships, alliances, and advisory networks within healthcare investment ecosystems. - Target markets/customers: institutional investors and public market participants seeking exposure to a healthcare-focused platform; eventual target entities would include hospital systems, clinics, pharmaceutical or diagnostics companies, medical technology firms, or healthcare service providers. - Geographic operations: U.S.-based vehicle with global or international transaction scope; operations centered in the United States, with potential cross-border deal opportunities given the global healthcare landscape. - Founding year and headquarters: incorporated as a SPAC for the purpose of completing a business combination; headquarters location stated in filings is within the United States, aligning with common SPAC practices for U.S. listings. - Subsidiaries/parent relationships: as a shell company, Amanat Acquisition Corp does not have operating subsidiaries prior to a business combination; post-transaction, the surviving company may inherit the target’s subsidiaries or form a newly consolidated corporate structure depending on the deal terms. Notes - Amanat Acquisition Corp is positioned as a healthcare-focused SPAC seeking to consummate a business combination with a healthcare or healthcare-related entity; the latest disclosed activity centers on IPO planning, SEC filings, and listing preparations under the AMAN ticker, with strategic emphasis on healthcare sector alignment. - For investors, key considerations include the timing of the IPO, the size and terms of the trust, potential deal timing within the 24-month horizon, and the identification of a qualified healthcare target that aligns with sponsor objectives and regulatory expectations.

Company News

  • Amanat Acquisition (NASDAQ:AMAN) Posts Quarterly Earnings Results

  • Corxel US and Amanat Acquisition Corp Announce Definitive Business Combination Agreement to Create Publicly Listed Obesity-Focused Biopharmaceutical Company

  • Amanat Acquisition Corp. (NASDAQ:AMAN) Shares Shorted: Short Interest Down 50.6% in September